Kevin Caliendo
Stock Analyst at UBS
(3.96)
# 1,809
Out of 4,966 analysts
401
Total ratings
55%
Success rate
5.6%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Reiterated: Buy | $361 → $380 | $311.54 | +21.97% | 22 | Sep 11, 2026 | |
| DGX Quest Diagnostics | Reiterated: Hold | $232 → $245 | $235.02 | +4.25% | 20 | Sep 8, 2026 | |
| CVS CVS Health | Rated: Buy | $126 → $118 | $94.66 | +24.66% | 36 | Sep 3, 2026 | |
| AHCO AdaptHealth | Rated: Buy | $10 | $5.97 | +67.50% | 19 | Aug 24, 2026 | |
| SDGR Schrödinger | Initiated Coverage: Hold | $19 | $19.02 | -0.11% | 1 | Aug 14, 2026 | |
| ACH Accendra Health | Reiterated: Hold | $4.5 → $1.5 | $1.08 | +38.89% | 20 | Aug 13, 2026 | |
| GDRX GoodRx Holdings | Reiterated: Hold | $2 → $3.75 | $3.35 | +12.11% | 9 | Aug 13, 2026 | |
| COR Cencora | Reiterated: Buy | $412 → $430 | $321.57 | +33.72% | 27 | Aug 6, 2026 | |
| MCK McKesson | Reiterated: Buy | $1,050 → $1,080 | $880.68 | +22.63% | 33 | Aug 6, 2026 | |
| HSIC Henry Schein | Reiterated: Hold | $89 → $94 | $88.36 | +6.38% | 11 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $33 | $23.47 | +40.61% | 3 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $50 | $32.53 | +53.70% | 3 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $186 → $189 | $150.82 | +25.31% | 26 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $260 → $274 | $234.57 | +16.81% | 23 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $6.16 | -2.60% | 16 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $4.15 | +20.63% | 8 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $13 | $12.97 | +0.23% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $17 | $10.46 | +62.52% | 20 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $82 → $78 | $87.45 | -10.81% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $390 → $375 | $280.76 | +33.57% | 11 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $22 → $25 | $25.55 | -2.15% | 5 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $18 | $12.61 | +42.74% | 13 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $374 → $180 | $200.45 | n/a | 7 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $9 | $13.00 | n/a | 9 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $250 → $285 | $403.47 | n/a | 12 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $72 → $79 | $66.42 | n/a | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $520 → $640 | $379.09 | n/a | 10 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $595 → $610 | $418.72 | n/a | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $180 → $175 | $265.58 | n/a | 4 | Oct 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $15.01 | n/a | 1 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 → $10 | $37.09 | n/a | 5 | Feb 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $8 | $4.60 | n/a | 2 | Mar 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $109.82 | n/a | 1 | Jan 30, 2018 |
Labcorp Holdings
Sep 11, 2026
Reiterated: Buy
Price Target: $361 → $380
Current: $311.54
Upside: +21.97%
Quest Diagnostics
Sep 8, 2026
Reiterated: Hold
Price Target: $232 → $245
Current: $235.02
Upside: +4.25%
CVS Health
Sep 3, 2026
Rated: Buy
Price Target: $126 → $118
Current: $94.66
Upside: +24.66%
AdaptHealth
Aug 24, 2026
Rated: Buy
Price Target: $10
Current: $5.97
Upside: +67.50%
Schrödinger
Aug 14, 2026
Initiated Coverage: Hold
Price Target: $19
Current: $19.02
Upside: -0.11%
Accendra Health
Aug 13, 2026
Reiterated: Hold
Price Target: $4.5 → $1.5
Current: $1.08
Upside: +38.89%
GoodRx Holdings
Aug 13, 2026
Reiterated: Hold
Price Target: $2 → $3.75
Current: $3.35
Upside: +12.11%
Cencora
Aug 6, 2026
Reiterated: Buy
Price Target: $412 → $430
Current: $321.57
Upside: +33.72%
McKesson
Aug 6, 2026
Reiterated: Buy
Price Target: $1,050 → $1,080
Current: $880.68
Upside: +22.63%
Henry Schein
Aug 5, 2026
Reiterated: Hold
Price Target: $89 → $94
Current: $88.36
Upside: +6.38%
Jul 30, 2026
Reiterated: Buy
Price Target: $37 → $33
Current: $23.47
Upside: +40.61%
Jul 29, 2026
Reiterated: Buy
Price Target: $57 → $50
Current: $32.53
Upside: +53.70%
Jul 23, 2026
Reiterated: Hold
Price Target: $186 → $189
Current: $150.82
Upside: +25.31%
Jul 20, 2026
Rated: Buy
Price Target: $260 → $274
Current: $234.57
Upside: +16.81%
May 15, 2026
Reiterated: Hold
Price Target: $6
Current: $6.16
Upside: -2.60%
May 8, 2026
Reiterated: Buy
Price Target: $5
Current: $4.15
Upside: +20.63%
May 8, 2026
Reiterated: Buy
Price Target: $12 → $13
Current: $12.97
Upside: +0.23%
May 7, 2026
Reiterated: Buy
Price Target: $18 → $17
Current: $10.46
Upside: +62.52%
May 6, 2026
Reiterated: Hold
Price Target: $82 → $78
Current: $87.45
Upside: -10.81%
Feb 9, 2026
Reiterated: Buy
Price Target: $390 → $375
Current: $280.76
Upside: +33.57%
Feb 3, 2026
Reiterated: Hold
Price Target: $22 → $25
Current: $25.55
Upside: -2.15%
Oct 31, 2025
Reiterated: Hold
Price Target: $17 → $18
Current: $12.61
Upside: +42.74%
Jul 25, 2025
Reiterated: Hold
Price Target: $374 → $180
Current: $200.45
Upside: n/a
May 8, 2025
Reiterated: Hold
Price Target: $12 → $9
Current: $13.00
Upside: n/a
Feb 24, 2025
Reiterated: Hold
Price Target: $250 → $285
Current: $403.47
Upside: n/a
Dec 21, 2023
Reiterated: Hold
Price Target: $72 → $79
Current: $66.42
Upside: n/a
Oct 16, 2023
Upgraded: Buy
Price Target: $520 → $640
Current: $379.09
Upside: n/a
Oct 24, 2022
Reiterated: Buy
Price Target: $595 → $610
Current: $418.72
Upside: n/a
Oct 3, 2022
Reiterated: Hold
Price Target: $180 → $175
Current: $265.58
Upside: n/a
Mar 9, 2022
Upgraded: Buy
Price Target: n/a
Current: $15.01
Upside: n/a
Feb 10, 2022
Reiterated: Hold
Price Target: $11 → $10
Current: $37.09
Upside: n/a
Mar 3, 2020
Reiterated: Hold
Price Target: $12 → $8
Current: $4.60
Upside: n/a
Jan 30, 2018
Upgraded: Buy
Price Target: n/a
Current: $109.82
Upside: n/a